JP2019516785A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019516785A5 JP2019516785A5 JP2019508294A JP2019508294A JP2019516785A5 JP 2019516785 A5 JP2019516785 A5 JP 2019516785A5 JP 2019508294 A JP2019508294 A JP 2019508294A JP 2019508294 A JP2019508294 A JP 2019508294A JP 2019516785 A5 JP2019516785 A5 JP 2019516785A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- cancer
- binding domain
- seq
- domain according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 4
- 208000006673 asthma Diseases 0.000 claims 4
- 208000015181 infectious disease Diseases 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 208000014018 liver neoplasm Diseases 0.000 claims 3
- 102000009027 Albumins Human genes 0.000 claims 2
- 108010088751 Albumins Proteins 0.000 claims 2
- 206010001889 Alveolitis Diseases 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 2
- 206010003827 Autoimmune hepatitis Diseases 0.000 claims 2
- 208000023328 Basedow disease Diseases 0.000 claims 2
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 claims 2
- 208000033222 Biliary cirrhosis primary Diseases 0.000 claims 2
- 208000006386 Bone Resorption Diseases 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 102000014914 Carrier Proteins Human genes 0.000 claims 2
- 108010078791 Carrier Proteins Proteins 0.000 claims 2
- 206010008342 Cervix carcinoma Diseases 0.000 claims 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 2
- 208000015943 Coeliac disease Diseases 0.000 claims 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 208000011231 Crohn disease Diseases 0.000 claims 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims 2
- 206010014824 Endotoxic shock Diseases 0.000 claims 2
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 2
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 2
- 206010072579 Granulomatosis with polyangiitis Diseases 0.000 claims 2
- 208000015023 Graves' disease Diseases 0.000 claims 2
- 208000035895 Guillain-Barré syndrome Diseases 0.000 claims 2
- 206010021143 Hypoxia Diseases 0.000 claims 2
- 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 claims 2
- 208000010159 IgA glomerulonephritis Diseases 0.000 claims 2
- 206010021263 IgA nephropathy Diseases 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 2
- 208000016604 Lyme disease Diseases 0.000 claims 2
- 206010025598 Malignant hydatidiform mole Diseases 0.000 claims 2
- 208000027530 Meniere disease Diseases 0.000 claims 2
- 206010049567 Miller Fisher syndrome Diseases 0.000 claims 2
- 206010029260 Neuroblastoma Diseases 0.000 claims 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 2
- 208000001132 Osteoporosis Diseases 0.000 claims 2
- 206010033128 Ovarian cancer Diseases 0.000 claims 2
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 2
- 206010033645 Pancreatitis Diseases 0.000 claims 2
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 claims 2
- 241000721454 Pemphigus Species 0.000 claims 2
- 208000004362 Penile Induration Diseases 0.000 claims 2
- 208000020758 Peyronie disease Diseases 0.000 claims 2
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 2
- 206010060932 Postoperative adhesion Diseases 0.000 claims 2
- 208000012654 Primary biliary cholangitis Diseases 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- 206010038389 Renal cancer Diseases 0.000 claims 2
- 208000006265 Renal cell carcinoma Diseases 0.000 claims 2
- 206010039491 Sarcoma Diseases 0.000 claims 2
- 206010039710 Scleroderma Diseases 0.000 claims 2
- 206010040070 Septic Shock Diseases 0.000 claims 2
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 2
- 208000006011 Stroke Diseases 0.000 claims 2
- 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 claims 2
- 206010052779 Transplant rejections Diseases 0.000 claims 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 2
- 206010047115 Vasculitis Diseases 0.000 claims 2
- 206010003246 arthritis Diseases 0.000 claims 2
- 201000008937 atopic dermatitis Diseases 0.000 claims 2
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 claims 2
- 201000004982 autoimmune uveitis Diseases 0.000 claims 2
- 230000024279 bone resorption Effects 0.000 claims 2
- 210000003169 central nervous system Anatomy 0.000 claims 2
- 201000010881 cervical cancer Diseases 0.000 claims 2
- 230000015271 coagulation Effects 0.000 claims 2
- 238000005345 coagulation Methods 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 206010014599 encephalitis Diseases 0.000 claims 2
- 201000004101 esophageal cancer Diseases 0.000 claims 2
- 201000001155 extrinsic allergic alveolitis Diseases 0.000 claims 2
- 230000003176 fibrotic effect Effects 0.000 claims 2
- 208000020694 gallbladder disease Diseases 0.000 claims 2
- 206010017758 gastric cancer Diseases 0.000 claims 2
- 208000024908 graft versus host disease Diseases 0.000 claims 2
- 210000003780 hair follicle Anatomy 0.000 claims 2
- 201000010536 head and neck cancer Diseases 0.000 claims 2
- 208000014829 head and neck neoplasm Diseases 0.000 claims 2
- 208000019622 heart disease Diseases 0.000 claims 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims 2
- 208000022098 hypersensitivity pneumonitis Diseases 0.000 claims 2
- 230000007954 hypoxia Effects 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 208000014674 injury Diseases 0.000 claims 2
- 208000023589 ischemic disease Diseases 0.000 claims 2
- 201000010982 kidney cancer Diseases 0.000 claims 2
- 201000007270 liver cancer Diseases 0.000 claims 2
- 201000005202 lung cancer Diseases 0.000 claims 2
- 208000020816 lung neoplasm Diseases 0.000 claims 2
- 206010025135 lupus erythematosus Diseases 0.000 claims 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 201000001441 melanoma Diseases 0.000 claims 2
- 201000011475 meningoencephalitis Diseases 0.000 claims 2
- 230000001394 metastastic effect Effects 0.000 claims 2
- 206010061289 metastatic neoplasm Diseases 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- 201000000050 myeloid neoplasm Diseases 0.000 claims 2
- 208000010125 myocardial infarction Diseases 0.000 claims 2
- 201000008482 osteoarthritis Diseases 0.000 claims 2
- 201000002528 pancreatic cancer Diseases 0.000 claims 2
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 2
- 201000001245 periodontitis Diseases 0.000 claims 2
- 210000001428 peripheral nervous system Anatomy 0.000 claims 2
- 206010034674 peritonitis Diseases 0.000 claims 2
- 201000008824 placental choriocarcinoma Diseases 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- 201000000306 sarcoidosis Diseases 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 201000011549 stomach cancer Diseases 0.000 claims 2
- 238000001356 surgical procedure Methods 0.000 claims 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 201000002510 thyroid cancer Diseases 0.000 claims 2
- 230000008733 trauma Effects 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 102000007562 Serum Albumin Human genes 0.000 claims 1
- 108010071390 Serum Albumin Proteins 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 230000002538 fungal effect Effects 0.000 claims 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 244000045947 parasite Species 0.000 claims 1
- 230000003071 parasitic effect Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022075986A JP2022115961A (ja) | 2016-05-01 | 2022-05-02 | 親和性を操作した血清タンパク質担体結合ドメイン |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1607636.6 | 2016-05-01 | ||
| GBGB1607636.6A GB201607636D0 (en) | 2016-05-01 | 2016-05-01 | Molecules & method |
| GB1607828.9 | 2016-05-04 | ||
| GBGB1607828.9A GB201607828D0 (en) | 2016-05-04 | 2016-05-04 | Method |
| PCT/EP2017/060266 WO2017191062A1 (en) | 2016-05-01 | 2017-04-28 | Affinity engineered serum protein carrier binding domain |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022075986A Division JP2022115961A (ja) | 2016-05-01 | 2022-05-02 | 親和性を操作した血清タンパク質担体結合ドメイン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019516785A JP2019516785A (ja) | 2019-06-20 |
| JP2019516785A5 true JP2019516785A5 (enExample) | 2020-05-28 |
| JP7133544B2 JP7133544B2 (ja) | 2022-09-08 |
Family
ID=58707502
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019508294A Active JP7133544B2 (ja) | 2016-05-01 | 2017-04-28 | 親和性を操作した血清タンパク質担体結合ドメイン |
| JP2022075986A Abandoned JP2022115961A (ja) | 2016-05-01 | 2022-05-02 | 親和性を操作した血清タンパク質担体結合ドメイン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022075986A Abandoned JP2022115961A (ja) | 2016-05-01 | 2022-05-02 | 親和性を操作した血清タンパク質担体結合ドメイン |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11466076B2 (enExample) |
| EP (1) | EP3452506B1 (enExample) |
| JP (2) | JP7133544B2 (enExample) |
| CN (1) | CN109071643B (enExample) |
| BR (1) | BR112018071288A2 (enExample) |
| CA (1) | CA3022494A1 (enExample) |
| ES (1) | ES3035839T3 (enExample) |
| WO (1) | WO2017191062A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3824906A1 (en) | 2016-12-21 | 2021-05-26 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| GB201811368D0 (en) * | 2018-07-11 | 2018-08-29 | Ucb Biopharma Sprl | Antibody |
| WO2020176478A1 (en) | 2019-02-25 | 2020-09-03 | The University Of Chicago | Methods and compositions for treating inflammatory and autoimmune conditions with ecm-affinity peptides linked to anti-inflammatory agents |
| CA3198049A1 (en) | 2020-10-15 | 2022-04-21 | UCB Biopharma SRL | Binding molecules that multimerise cd45 |
| GB202318820D0 (en) | 2023-12-08 | 2024-01-24 | UCB Biopharma SRL | Antibodies |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| GB9113120D0 (en) | 1991-06-18 | 1991-08-07 | Kodak Ltd | Photographic processing apparatus |
| DK1644412T4 (en) | 2003-07-01 | 2018-11-12 | Ucb Biopharma Sprl | MODIFIED ANTIBODY-FAB FRAGMENTS |
| GB0315457D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| GB0315450D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| GB0411186D0 (en) | 2004-05-19 | 2004-06-23 | Celltech R&D Ltd | Biological products |
| ES2622460T3 (es) * | 2007-09-26 | 2017-07-06 | Ucb Biopharma Sprl | Fusiones de anticuerpos con doble especificidad |
| SI2334705T1 (sl) | 2008-09-26 | 2017-05-31 | Ucb Biopharma Sprl | Biološki produkti |
| MX351502B (es) * | 2011-11-11 | 2017-10-18 | Ucb Pharma Sa | Anticuerpos de union de albumina y fragmentos de union de los mismos. |
| GB201223276D0 (en) * | 2012-12-21 | 2013-02-06 | Ucb Pharma Sa | Antibodies and methods of producing same |
| US10407508B2 (en) * | 2013-07-08 | 2019-09-10 | Nanjing Legend Biotech., Ltd. | Compositions and methods for increasing protein half-life in a serum |
| GB201411320D0 (en) | 2014-06-25 | 2014-08-06 | Ucb Biopharma Sprl | Antibody construct |
-
2017
- 2017-04-28 JP JP2019508294A patent/JP7133544B2/ja active Active
- 2017-04-28 WO PCT/EP2017/060266 patent/WO2017191062A1/en not_active Ceased
- 2017-04-28 CA CA3022494A patent/CA3022494A1/en active Pending
- 2017-04-28 BR BR112018071288-4A patent/BR112018071288A2/pt active Search and Examination
- 2017-04-28 EP EP17723304.6A patent/EP3452506B1/en active Active
- 2017-04-28 CN CN201780027100.5A patent/CN109071643B/zh active Active
- 2017-04-28 ES ES17723304T patent/ES3035839T3/es active Active
- 2017-04-28 US US16/098,085 patent/US11466076B2/en active Active
-
2022
- 2022-05-02 JP JP2022075986A patent/JP2022115961A/ja not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019516785A5 (enExample) | ||
| JP2020513804A5 (enExample) | ||
| HRP20161069T1 (hr) | Molekule antitijela koje vezuju il-17a i il-17f | |
| HRP20141214T1 (hr) | Molekule antitijela sa specifiäśnosti za humani 6-il | |
| JP2015525768A5 (enExample) | ||
| JP2019503167A5 (enExample) | ||
| JP2020501532A5 (enExample) | ||
| JP2019514876A5 (enExample) | ||
| JP2011083291A5 (enExample) | ||
| JP2019506841A5 (enExample) | ||
| JP2019514882A5 (enExample) | ||
| JP2019531093A5 (enExample) | ||
| JP2019523753A5 (enExample) | ||
| JP2018538281A5 (enExample) | ||
| JP2018198596A5 (enExample) | ||
| JP2014515602A5 (enExample) | ||
| JP2016517273A5 (enExample) | ||
| JP2010273685A5 (enExample) | ||
| JP2017507181A5 (enExample) | ||
| JP2017536412A5 (enExample) | ||
| JP2015523323A5 (enExample) | ||
| HRP20231264T1 (hr) | Protutijela protiv csf-1r | |
| JP2015096070A5 (enExample) | ||
| JP2018524001A5 (enExample) | ||
| WO2017009308A3 (en) | Antibodies specific for hyperphosphorylated tau and methods of use thereof |